Search for instruments

Nektar Therapeutics
Nektar Therapeutics is a leading biopharmaceutical company that specializes in developing innovative medicines to address unmet medical needs. With a focus on cancer, autoimmune diseases, and chronic pain, Nektar's proprietary drug delivery technology platform, PEGylation, enables the development of drugs with improved efficacy, safety, and convenience. The company has a robust pipeline of drug candidates in various stages of development, including NKTR-214, a potential treatment for multiple types of cancer, and NKTR-181, a novel opioid analgesic for chronic pain. Nektar is dedicated to improving the lives of patients through the development of transformative medicines and advancing the field of drug delivery technology.Instrument specification in OANDA
Start trading now with fast account opening.
Sign-up now to trade the most active markets
Open account